Dynavax Technologies Corporation (DVAX)
Add to Watchlists Create an AlertDVAX Key Stats
| Income Statement | |
| Revenue TTM | 9.449M |
| Revenue Quarterly YoY Growth | -11.28% |
| EPS Diluted TTM | -0.4136 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -74.27M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | -998.8% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 459.03M |
| Enterprise Value | 355.49M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 4.688 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow | -8.796M |
| Return on Equity | -64.48% |
DVAX News
- Biotech Investing for Beginners Fool May 22
- Due Diligence in Finding the Value of Pharmaceuticals: Expert Portfolio Manager ... May 16
- See What These $15 Billion Managers Have Been Buying May 14
- 3 Investment Strategy Lessons From Vertex's Success May 11
- DYNAVAX TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report May 9
- Wider-than-Expected Loss at Dynavax May 7
- Wider-than-Expected Loss at Dynavax - Analyst Blog Zacks May 7
- Dynavax Technologies Corp (DVAX) Reports In-Line Q1 EPS Street Insider May 6
- Dynavax Reports First Quarter 2013 Financial Results Marketwired May 6
- DYNAVAX TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financia... May 6
DVAX Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Dynavax Technologies Corporation is down 29.69% over the last year vs S&P 500 Total Return up 28.45%, GlaxoSmithKline up 24.84%, and Anika Therapeutics up 3.06%.
DVAX Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these DVAX related companies
Pro Ratings for DVAX
Pro Report PDF for DVAX
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download DVAX Pro Report PDF
Pro Strategies Featuring DVAX
Did Dynavax Technologies Corporation make it into our Pro Portfolio Strategies?
DVAX Profile
Sector: Healthcare
Industry: Biotechnology
Other DVAX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| DVAX | 2.51 | -0.01 | -0.40% | 459.03M |
